Genetics Generation Advancement Corp.
4160
Rank in Stocks
#24906
Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan,... Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan, specializes in providing advanced genetic testing and bioinformatics solutions. The company serves a diverse global clientele across Taiwan, Asia, Europe, and the Americas. GGAC offers a comprehensive array of genetic screenings tailored for various life stages and health needs. These include pre-conception, prenatal, and newborn testing, in addition to adult health management, cancer predisposition, and pharmacogenetic analyses. The company also collaborates with and provides services to institutional partners. Beyond its core genetic services, Genetics Generation Advancement Corp. extends its expertise to encompass life sciences, materials science, sophisticated laboratory informatics, enterprise quality management systems (EQMS), Manufacturing Execution Systems (MES), and efficient electronic data delivery solutions. Originally founded in 2008 as Genesis Genetics Asia Corp., the company officially rebranded and adopted its current name, Genetics Generation Advancement Corp., in February 2016.
Share Price
$1.06
Last synced: 2026-11-10
Market Cap
$29.68M
Change (1 day)
0.14%
Change (1 year)
-38.17%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genetics Generation Advancement Corp. (4160)
Category
Healthcare
EPS for Genetics Generation Advancement Corp. (4160)
EPS as of June 2026 TTM: $0.02
According to Genetics Generation Advancement Corp.'s latest financial reports, its current EPS (TTM) is $0.02. At the end of 2025 the company had an EPS of $0.03, a decrease compared to its 2024 EPS of $0.06.
EPS history for Genetics Generation Advancement Corp. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.02 | -30.00% |
| 2025 | $0.03 | -59.20% |
| 2024 | $0.06 | 79.08% |
| 2023 | $0.03 | 6.08% |
| 2022 | $0.03 | 193.75% |
| 2021 | $0.01 | -150.68% |
| 2020 | $-0.02 | -197.36% |
| 2019 | $0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | 90,328.57% |
US
|
|
| $6.12 | 29,042.86% |
US
|
|
| $1.38 | 6,457.62% |
CN
|
|
| $14.83 | 70,519.05% |
US
|
|
| $5.09 | 24,138.10% |
US
|
Questions about Genetics Generation Advancement Corp.'s earnings per share (EPS)
What is Genetics Generation Advancement Corp.'s earnings per share (EPS)?
Genetics Generation Advancement Corp.'s earnings per share (EPS) over the last twelve months is $0.02, as of Jun 2026.
What was Genetics Generation Advancement Corp.'s earnings per share (EPS) in 2025?
In 2025, Genetics Generation Advancement Corp.'s earnings per share (EPS) was $0.03, 50.00% less than in 2024 ($0.06).
How has Genetics Generation Advancement Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Genetics Generation Advancement Corp.'s earnings per share (EPS) was highest in 2024 ($0.06) and lowest in 2020 ($-0.02).
How does Genetics Generation Advancement Corp.'s earnings per share (EPS) compare with similar companies?
Genetics Generation Advancement Corp.'s earnings per share (EPS) ($0.02) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.